Rafet Başar
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 24
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 4
- Oncology 25
- CAR-T cell therapy research 20
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Katayoun Rezvani (17 shared papers)May Daher (12 shared papers)Muharrem Müftüoğlu (8 shared papers)Elizabeth J. Shpall (9 shared papers)Hila Shaim (7 shared papers)Sema Çiftçi Doğanşen (1 shared paper)Neşe Özbey (1 shared paper)Sevgi Kalayoğlu Beşışık (1 shared paper)
- Journals
- Blood (11 papers)Frontiers in Immunology (6 papers)Blood Advances (4 papers)Nature Medicine (3 papers)Leukemia (3 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Rafet Başar
53 papers receiving 6.9k citations
Rafet Başar's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 3.8k
- Immunology 2.6k
- Genetics 333
- Hematology 297
- Cancer Research 154
Countries citing papers authored by Rafet Başar
This map shows the geographic impact of Rafet Başar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafet Başar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafet Başar more than expected).
Fields of papers citing papers by Rafet Başar
This network shows the impact of papers produced by Rafet Başar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafet Başar. The network helps show where Rafet Başar may publish in the future.
Co-authors
The 25 scholars most cited alongside Rafet Başar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | B cells and tertiary lymphoid structures promote immunotherapy response Hit paper breakdown → | 2020 | 2032 |
| 2 | Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors Hit paper breakdown → | 2020 | 1766 |
| 3 | Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity Hit paper breakdown → | 2017 | 697 |
| 4 | Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial Hit paper breakdown → | 2024 | 369 |
| 5 | 2020 | 250 | |
| 6 | 2021 | 216 | |
| 7 | 2022 | 147 | |
| 8 | 2021 | 129 | |
| 9 | 2020 | 118 | |
| 10 | 2017 | 108 | |
| 11 | 2023 | 88 | |
| 12 | 2016 | 85 | |
| 13 | 2024 | 59 | |
| 14 | 2013 | 57 | |
| 15 | 2021 | 56 | |
| 16 | 2016 | 53 | |
| 17 | 2021 | 50 | |
| 18 | 2016 | 49 | |
| 19 | 2020 | 48 | |
| 20 | 2021 | 48 |
About Rafet Başar
Rafet Başar is a scholar working on Immunology, Oncology, Genetics, Hematology and Molecular Biology, having authored 58 papers that have together received 7.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (20 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Single-cell and spatial transcriptomics (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Oncology (3.8k citations), Immunology (2.6k citations), Genetics (333 citations), Hematology (297 citations) and Cancer Research (154 citations). Rafet Başar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Katayoun Rezvani, May Daher, Muharrem Müftüoğlu, Elizabeth J. Shpall, Hila Shaim, Sema Çiftçi Doğanşen, Neşe Özbey, Sevgi Kalayoğlu Beşışık, Ferihan Aral and Ayşe Kubat Üzüm. Their work appears in journals such as Blood, Frontiers in Immunology, Blood Advances, Nature Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.